Literature DB >> 12351405

Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors.

Stéphane Giraudier1, Hédia Chagraoui, Emiko Komura, Stéphane Barnache, Benoit Blanchet, Jean Pierre LeCouedic, David F Smith, Frédéric Larbret, Anne-Laure Taksin, Françoise Moreau-Gachelin, Nicole Casadevall, Michel Tulliez, Anne Hulin, Najet Debili, William Vainchenker.   

Abstract

Idiopathic myelofibrosis (IMF) is a chronic myeloproliferative disorder characterized by megakaryocyte hyperplasia and bone marrow fibrosis. Biologically, an autonomous megakaryocyte growth and differentiation is noticed, which contributes to the megakaryocyte accumulation. To better understand the molecular mechanisms involved in this spontaneous growth, we searched for genes differentially expressed between normal megakaryocytes requiring cytokines to grow and IMF spontaneously proliferating megakaryocytes. Using a differential display technique, we found that the immunophilin FKBP51 was 2 to 8 times overexpressed in megakaryocytes derived from patients' CD34(+) cells in comparison to normal megakaryocytes. Overexpression was moderate and confirmed in 8 of 10 patients, both at the mRNA and protein levels. Overexpression of FKBP51 in a UT-7/Mpl cell line and in normal CD34(+) cells induced a resistance to apoptosis mediated by cytokine deprivation with no effect on proliferation. FKBP51 interacts with both calcineurin and heat shock protein (HSP)70/HSP90. However, a mutant FKBP51 deleted in the HSP70/HSP90 binding site kept the antiapoptotic effect, suggesting that the calcineurin pathway was responsible for the FKBP51 effect. Overexpression of FKBP51 in UT-7/Mpl cells induced a marked inhibition of calcineurin activity. Pharmacologic inhibition of calcineurin by cyclosporin A mimicked the effect of FKBP51. The data support the conclusion that FKBP51 inhibits apoptosis through a calcineurin-dependent pathway. In conclusion, FKBP51 is overexpressed in IMF megakaryocytes and this overexpression could be, in part, responsible for the megakaryocytic accumulation observed in this disorder by regulating their apoptotic program.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12351405     DOI: 10.1182/blood-2002-02-0485

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

1.  Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids.

Authors:  Tina R Hubler; Jonathan G Scammell
Journal:  Cell Stress Chaperones       Date:  2004       Impact factor: 3.667

Review 2.  Calcineurin regulation in fungi and beyond.

Authors:  Jamal Stie; Deborah Fox
Journal:  Eukaryot Cell       Date:  2007-12-07

3.  Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder.

Authors:  Erick T Tatro; Ian P Everall; Marcus Kaul; Cristian L Achim
Journal:  Brain Res       Date:  2009-06-21       Impact factor: 3.252

Review 4.  The JAK2(V617F) tyrosine kinase mutation in myeloproliferative disorders: Summary of published literature and a perspective.

Authors:  Martha Wadleigh; D Gary Gilliland
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

5.  DYRK1A in Down syndrome: an oncogene or tumor suppressor?

Authors:  Yehudit Birger; Shai Izraeli
Journal:  J Clin Invest       Date:  2012-02-22       Impact factor: 14.808

6.  Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome.

Authors:  Sébastien Malinge; Meghan Bliss-Moreau; Gina Kirsammer; Lauren Diebold; Timothy Chlon; Sandeep Gurbuxani; John D Crispino
Journal:  J Clin Invest       Date:  2012-02-22       Impact factor: 14.808

7.  The calcineurin-NFAT pathway negatively regulates megakaryopoiesis.

Authors:  Alexander Zaslavsky; Stella T Chou; Keri Schadler; Allyson Lieberman; Maxim Pimkin; Yeo Jung Kim; Kwan-Hyuck Baek; William C Aird; Mitchell J Weiss; Sandra Ryeom
Journal:  Blood       Date:  2013-02-27       Impact factor: 22.113

8.  Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression.

Authors:  Liang Li; Brooke Fridley; Krishna Kalari; Gregory Jenkins; Anthony Batzler; Stephanie Safgren; Michelle Hildebrandt; Matthew Ames; Daniel Schaid; Liewei Wang
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

Review 9.  The emerging role of large immunophilin FK506 binding protein 51 in cancer.

Authors:  S Romano; A Sorrentino; A L Di Pace; G Nappo; C Mercogliano; M F Romano
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

10.  FK506-binding protein 51 is a possible novel tumoral marker.

Authors:  S Romano; A D'Angelillo; S Staibano; G Ilardi; M F Romano
Journal:  Cell Death Dis       Date:  2010-07-15       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.